With 15 years of B2B tech marketing experience, I work with deeptech companies as they move from lab to market: finding the first use cases that pay, speaking to industrial buyers and investors alike, and building a credible brand before the product is even finished.

A deeptech technology often opens the door to many markets, and the temptation is to keep them all open as long as possible, when it's precisely by choosing the first use case early that you speed up development, fundraising and first revenue.
I help teams compare these options on simple criteria, how urgent the problem is for the customer, how easy it is to prove value and how accessible the first buyers are, to focus energy where the market is ready to pay.
Well before the product is finished. Marketing helps choose the first market, prepare pilots and convince investors, all decisions that influence how the technology will be developed.
Four workstreams, adapted to where the company starts from:
By starting from their operational problem and the outcome they can measure, then explaining the technology only insofar as it makes that outcome credible, with proof from tests or pilots.
That's the work I'm doing with Aurora Stérilisation, from cold plasma technology to market entry, and it's the same approach I offer teams who want to go from lab to market.
Yes, clear positioning, a chosen first market and a credible brand strengthen a fundraising case, because investors want to understand how the technology will find its first customers.
30 minutes to identify the first use case to lead with, and the messaging that goes with it.